Inhibition of cow’s milk allergy development in mice by oral delivery of β‐lactoglobulin‐derived peptides loaded PLGA nanoparticles is associated with systemic whey‐specific immune silencing

BACKGROUND: Two to four percentage of infants are affected by cow's milk allergy (CMA), which persists in 20% of cases. Intervention approaches using early oral exposure to cow's milk protein or hydrolysed cow's milk formula are being studied for CMA prevention. Yet, concerns regardin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Mengshan, Thijssen, Suzan, van Nostrum, Cornelus F., Hennink, Wim E., Garssen, Johan, Willemsen, Linette E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291823/
https://www.ncbi.nlm.nih.gov/pubmed/34145667
http://dx.doi.org/10.1111/cea.13967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291823/
https://www.ncbi.nlm.nih.gov/pubmed/34145667
http://dx.doi.org/10.1111/cea.13967

Ejemplares similares